No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Aileron Therapeutics GAAP EPS of -$0.27 Misses by $0.02
Aileron Therapeutics | 10-Q: Q3 2024 Earnings Report
Express News | Aileron Therapeutics, Inc. Q3 Net Income USD -5.847 Million
Press Release: Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Aileron Therapeutics 3Q Loss/Shr 27c >ALRN
Aileron Therapeutics | 8-K: Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Unlock the Full List